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Neutral lipid storage disease (NLSD) is an autosomal
recessive disorder in which excess triacylglycerol (TG)
accumulates in most cells. Although it has been hypoth-
esized that the TG accumulation is caused by a func-
tional defect in cytosolic lipase activity, we were able to
expose TG hydrolysis in NLSD cells by using triacsin C,
an inhibitor of acyl-CoA synthetase that blocks the re-
incorporation of hydrolyzed fatty acids into glycerolip-
ids. Our data suggest that TG lipolysis in NLSD cells is
masked by rapid TG resynthesis, occurring because re-
leased acylglycerols cannot be used for phospholipid
synthesis. In uptake studies, triacsin C blocked the in-
corporation of [3H]glycerol into glycerolipids, incorpo-
ration of [14C]oleate into TG, but not incorporation of
[14C]oleate into phospholipid. Thus, the drug inhibited
both de novo synthesis of glycerolipids via the glycerol-
3-phosphate pathway and the synthesis of TG from di-
acylglycerol. The drug did not appear to block reacyla-
tion of lysophospholipids. Triacsin C caused a loss of
about 60% of the TG mass from both NLSD and oleate-
loaded control cells. Rates of TG lipolysis were similar in
NLSD cells and oleate-loaded control cells labeled with
[6-(7-nitro-2,1,3-benzoxadiazol-4-yl)-amino]hexanoic
acid or labeled with [14C]oleate or [3H]glycerol and
chased in the presence of triacsin C. During a 96-h
chase, [14C]oleate reincorporation into the different
phospholipid species increased only in control cells.
Similar results were observed when NLSD, and control
cells were chased after labeling with [3H]glycerol. These
data strongly suggest that normal human fibroblasts
mobilize stored TG for phospholipid synthesis and that
recycling to PC occurs via a TG-derived mono- or di-
acylglycerol intermediate. Normal recycling to phos-
phatidylethanolamine may primarily involve TG-de-
rived acyl groups rather than an acylglycerol precursor.
NLSD cells appear to have a block in this recycling
pathwaywith the result that both hydrolyzed fatty acids
and the acylglycerol backbone are re-esterified to form
TG. Because the NLSD phenotype includes ichthyosis,
fatty liver, myopathy, cardiomyopathy, and mental re-
tardation, the recycling pathway appears to be critical
for the normal function of skin, liver, muscle, heart, and
the central nervous system.
Most cells are able to synthesize triacylglycerol (TG)1 and to
store it in cytosolic droplets, but the function and fate of stored
TG in non-adipose tissue has not been extensively investigated.
It has been suggested that diacylglycerol (DAG) derived from
stored TG may be recycled as a precursor for phospholipid
synthesis (1) or, in hepatocytes, for very low density lipoprotein
TG synthesis (2). The identification of a human genetic disor-
der in which cellular TG accumulation is associated with a
variety of clinical problems suggests that the metabolism of
cytosolic TG is critical for normal cell function.
Neutral lipid storage disease (NLSD) is an autosomal reces-
sive disorder in which most cells accumulate intracellular drop-
lets of TG. The clinical phenotype variably includes ichthyosis,
fatty liver, mental retardation, myopathy, ataxia, neurosen-
sory hearing loss, cataracts, and cardiomyopathy (3, 4). In
NLSD, the uptake, transport, and b-oxidation of fatty acids (5),
lipase and carboxyesterase activities (6–8), and several en-
zymes of glycerolipid synthesis (8) are all normal. Neverthe-
less, the TG content of NLSD lymphocytes (6), macrophages (9),
and fibroblasts (5) in culture is 5-, 2-, and 20-fold higher,
respectively, than in normal cells. Radiolabeled TG does not
deplete even when cells are placed in lipid-deficient medium (4,
5, 10). Unlike the lipase/cholesterol esterase deficiency of Wol-
man’s disease, the defect in NLSD is extra-lysosomal (10, 11),
and lipolysis of short chain TG may be normal (12). Salvayre’s
group has hypothesized that the NLSD cells might have a
functional block in cytosolic lipase activity such that even
though the lipase is normal in in vitro studies, it does not
function in situ (11, 12).
In order to understand the normal role of stored TG, we
examined recycling of TG’s fatty acid and glycerol moieties to
phospholipid in NLSD fibroblasts and in normal fibroblasts
that had been loaded with oleate to approximate the TG con-
tent of NLSD cells. Using the acyl-CoA synthetase inhibitor,
triacsin C, we were able to expose the extent of TG hydrolysis
by preventing the activation and reutilization of hydrolyzed
fatty acid (13, 14). Our studies show that NLSD cells are not
defective in lipase function but, instead, appear to have a defect
that involves abnormal recycling of TG-derived mono- or dia-
cylglycerols to specific phospholipids.
EXPERIMENTAL PROCEDURES
Materials—Silica gel G plates were from Whatman. [2-3H]Glycerol
and [1-14C]oleate were from Amersham Life Sciences Co. CDP-[14C]cho-
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line was from New England Nuclear. Glycerol, BSA (essentially fatty
acid-free), and sodium oleate were from Sigma. Lipid standards and
sn-1,2-dioleoylglycerol were from Serdary. C6-NBD, C6-NBD-PA, C6-
NBD-PC, and C6-NBD-PE were from Avanti Polar Lipids. Triacsin C
was from Biomol Research Lab, Inc. Tissue culture supplies and fetal
bovine serum were from Life Technologies, Inc.
Cell Culture—Normal human skin fibroblasts were obtained from
the American Type Tissue Culture Collection (cell line CCD). NLSD
fibroblasts were obtained with parental informed consent from a child
with lamellar ichthyosis, mental retardation, fatty liver with fibrosis
and cholestasis, and vacuolated neutrophils.2 Normal fibroblasts and
NLSD fibroblasts were cultured at 37 °C in a humidified atmosphere of
5% CO2 in minimum essential medium with Earle’s salts plus 1%
non-essential amino acids (E-MEM) and 10% fetal bovine serum (FBS)
that had been heat-inactivated for 60 min at 56 °C. The medium was
changed every 2–3 days. For each experiment total cellular DNA con-
tent was measured fluorometrically (15).
Cellular Triacylglycerol Mass Quantification—Normal and NLSD
fibroblasts were grown to confluence in 100-mm dishes. In order to
obtain a high cellular TG content, similar to that present in NLSD cells,
some control cells were incubated for 24 h with 1.0 mM sodium oleate in
1% BSA. This treatment produced abundant cytoplasmic lipid droplets
similar in appearance to those present in NLSD cells. Control and
NLSD cells were washed three times with 3 ml of 0.1% BSA in PBS.
Then 8 ml of fresh medium (E-MEM, 10% FBS, supplemented with 1%
BSA) was added in the presence of either 5 mM triacsin C in Me2SO
(0.1%) or in Me2SO alone. After 96 h, cell monolayers were washed once
with warm PBS, and the cells were trypsinized. DNA was measured in
aliquots from each cellular suspension. The remaining cells were pel-
leted by centrifugation, resuspended in water, and probe-sonicated
(three pulses of 15 s each). Cell lipids were extracted (16), and total TG
content was determined using a commercial kit (GPO-Trinder, Sigma
Co.).
Cell Radiolabeling with Oleic Acid—Fibroblasts were seeded in
60-mm dishes and grown to near confluence. The cultures were incu-
bated with 0.5 mCi of [14C]oleic acid in 3 ml of 10% FBS, E-MEM.
Sodium oleate (0.1 or 1.0 mM) was included in the labeling medium to
promote incorporation of label into TG. Sodium oleate was dissolved in
H2O at 65 °C and added to dry [
14C]oleate. Then 1% BSA (final concen-
tration) in E-MEM was added. After 24 h, the medium was removed,
and residual radiolabel was removed by washing the cells three times
with 0.1% BSA in PBS at 37 °C. Cells were then chased in 2 ml of 10%
FBS, E-MEM plus 0.1% BSA at 37 °C in the absence or the presence of
5 mM triacsin C dissolved in Me2SO. The medium was not replaced
during the chase. The concentration of Me2SO in the culture medium
never exceeded 0.2% (v/v). Triacsin treatment did not affect cell viabil-
ity. At the end of each incubation, the medium was removed, and the
cells were washed once with 0.1% BSA in 37 °C PBS. Cells were scraped
in two additions of 1 ml of methanol and 0.5 ml of H2O. 1 ml of CHCl3
was added, and total cell lipids were extracted (16) and concentrated
using a SpeedVac concentrator (Savant, Hicksville, NY).
Cell Radiolabeling with Glycerol—Near confluent monolayers of nor-
mal and NLSD fibroblasts in 60-mm dishes were incubated at 37 °C
with 2 mCi/ml [3H]glycerol (specific activity, 1.0 Ci/mol) in 10% FBS,
E-MEM, supplemented with 0.1 or 1.0 mM sodium oleate in 1% BSA.
After 20 h, the labeling medium was removed, and cells were washed
three times with 0.1% BSA in warm PBS to remove any residual label.
Control and NLSD fibroblasts were then chased for 24–96 h in 2 ml
E-MEM, 10% FBS, supplemented with 0.1% BSA in the presence or the
absence of 5 mM triacsin C in Me2SO (final Me2SO concentration was
0.1%, v/v). Mediumwas not replaced during the chase period. At the end
of each incubation, cells were washed with 1 ml of 0.1% BSA in PBS,
and lipids were extracted as described above.
Lipid Analysis—Aliquots of the lipid extracts were spotted on
0.25-mm silica gel G plates. Neutral lipids were resolved in heptane:
isopropylether:glacial acetic acid (60:40:4, v/v/v) with authentic stand-
ards. Phospholipids were separated in a double one-directional solvent
system. First, the plate was chromatographed in CHCl3:CH3OH:
NH4OH:H2O (70:25:3.5:1.5, v/v) to 3 cm from the top. The residual
solvents on the plate were evaporated, and the plate was rerun in the
same direction in CHCl3:CH3OH:glacial acetic acid:H2O (80:10:2:0.75,
v/v). 3H- and 14C-labeled lipid products were visualized using a BioScan
Image 200 System (Washington, D.C.). The 3H-labeled spots were
scraped into vials and counted in a liquid scintillation counter. The 14C
spots were quantified by the BioScan 200 system.
Measurement of Diacylglycerol Cholinephosphotransferase—Near
confluent normal and NLSD fibroblasts were scraped from the dishes
and homogenized in 10 mM Tris-Cl, pH 7.4, 1 mM EDTA, 0.25 M sucrose
with 30 up-and-down strokes in a motor-driven Teflon-glass homoge-
nizer and centrifuged at 100,000 3 g for 1 h. Total particulate prepa-
rations resuspended in the same buffer were used to measure diacyl-
glycerol cholinephosphotransferase. The assay included 100 mM CDP-
[14C]choline (10 mCi/mmol) and 100 mM sn-1,2-dioleoylglycerol added in
acetone (17).
C6-NBD-Phosphatidic Acid Incorporation into Cellular Lipids—Nor-
mal and NLSD fibroblasts were grown to near confluence in 100-mm
dishes. Control cells were first incubated with 1.0 mM sodium oleate in
1% BSA for 24 h in order to increase TG content. Then, normal and
NLSD fibroblasts were incubated for another 24 h with 5 mM C6-
NBD-PA (in 0.1% Me2SO) and 1.0 mM sodium oleate in 1% BSA. At the
end of this incubation, cells were washed three times with 0.1% BSA in
warm PBS to eliminate residual NBD-PA. Then cells were chased in
E-MEM, 10% FBS for 24–48 h. At the end of each incubation, fibro-
blasts were washed once with 0.1% BSA in PBS, and lipids were
extracted as described previously. C6-NBD-labeled lipids were sepa-
rated in a double one-directional solvent system with authentic stand-
ards. The C6-NBD-DAG standard was produced by phospholipase C
treatment of C6-NBD-PC. The C6-NBD-TG standard was synthesized
from C6-NBD-DAG (18). After chromatography with CHCl3:CH3OH:
30% NH4OH (65:35:5, v/v) to 10 cm, plates were air dried for 30 min and
then chromatographed to the top of the plate in CHCl3:CH3OH:
CH3COOH (100:2.5:5, v/v).
RESULTS
Triacylglycerol Mass Is Mobilized Similarly from Control
and NLSD Cells—Previous studies have shown that after TG
in normal fibroblasts is labeled with 14C-labeled fatty acid,
most of the radiolabeled TG disappears during a 24-h chase. In
contrast, radiolabeled TG in NLSD cells is not depleted (4, 5,
10). Because lipase activities are normal in NLSD cells, it has
been suggested that the lipase may require a missing cofactor,
be mislocalized, or be otherwise unable to reach the droplet TG
(11, 12). However, because the amount of endogenous TG in
normal fibroblasts is very low and that of NLSD cells is high,
we suspected that even normal cells would give the appearance
of a stable TG pool if radiolabeled TG were diluted into a large
unlabeled TG pool similar to that present in NLSD cells.
Confluent NLSD cell contained 17-fold more TG/mg DNA
than did control fibroblasts (Table I). When control fibroblasts
were incubated with 1.0 mM sodium oleate, their cellular TG
content increased 15-fold. The oleate-loaded control cells de-
pleted their TG content slowly; after a 96-h chase, the total TG
content in control cells decreased by only 15%. NLSD cells
maintain their high TG content under these conditions. In
order to block the possible re-esterification of any hydrolyzed
fatty acid, we incubated control and NLSD cells with triacsin C,
a potent inhibitor of acyl-CoA synthetase (13, 14). When cells2 R. A. Igal and R. A. Coleman, unpublished data.
TABLE I
Changes in TG mass in the presence or absence of triacsin C
Control and NLSD cells were seeded in 100-mm dishes and grown to
confluence in E-MEM, 10% FBS. All control cells were then incubated
for 24 h with 1.0 mM sodium oleate in E-MEM, 10% FBS and washed as
described under “Experimental Procedures.” NLSD cells were not pre-
incubated with sodium oleate. Control and NLSD cells were then placed
in fresh media (E-MEM, 10% FBS) in the presence or the absence of 5
mM triacsin C for 96 h. The numbers in parentheses indicate the number





Control in normal media
(Pool of 3 dishes)
224 0.9
1.0 mM oleate (2) 0 14.1
Chase (4) 96 12.0 6 0.5
Chase plus triacsin C (4) 96 8.4 6 0.2
NLSD in normal media (6) 96 15.6 6 0.3
Chase plus triacsin C (8) 96 8.7 6 0.3
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were incubated for 96 h in the presence of triacsin C, the
content of TG in both oleate-loaded control and NLSD fibro-
blasts each decreased by approximately 50% (Table I). Thus,
when fatty acid re-esterification was prevented, the two cell
lines showed no apparent difference in their ability to hydro-
lyze TG. Under these conditions, it appeared that 35 and 50%
of any fatty acid hydrolyzed from TG was being re-esterified
back to TG in oleate-loaded control and NLSD cells,
respectively.
Triacsin Exposes TG Hydrolysis in Control and NLSD
Cells—Phospholipid synthesis and deacylation/reacylation cy-
cles may be tightly controlled such that any excess fatty acid is
channeled to TG synthesis (1). In order to examine the fate of
hydrolyzed TG, we studied the turnover of [14C]oleate-labeled
glycerolipids in control cells whose TG content had been in-
creased to the level normally present in NLSD cells by incuba-
tion with 1.0 mM [14C]oleate. After 24 h, 90% of the incorpo-
rated label in control cells was present in the TG fraction. In
NLSD fibroblasts incubated with only 0.1 mM [14C]oleate, 75%
of the incorporated labeled fatty acid was present as TG (Fig.
1). The amount of radiolabel incorporated into TG by control
cells was three times higher than in NLSD cells, consistent
with a greater than 15-fold increase in TGmass in the presence
of 1.0 mM oleate (see Table I). In contrast, the amount of
[14C]oleic acid incorporated into phospholipids was similar in
both cell lines. These data are consistent with the view that
excess fatty acid is used for TG synthesis (1).
After a 48-h chase, [14C]TG in the oleate-loaded control cells
decreased by 60%, whereas no loss was observed in NLSD cells
(Fig. 1, A and B). However, when triacsin C was added during
the chase to block reutilization of hydrolyzed fatty acid, labeled
TG decreased 50% in NLSD cells and 70% in control cells by
48 h. This experiment confirms that NLSD cells contain a
functional TG lipase capable of hydrolyzing TG in lipid droplets
but that lipase activity is masked by rapid resynthesis of TG.
Without triacsin C, oleate-loaded control cells lose labeled TG
slowly, suggesting that both cell lines reduce their TG content
at similar rates and that previous reports showing rapid loss of
labeled fatty acid from control cells was likely due to their low
TG mass and the consequent difference in TG-specific activity
within the control and NLSD cells (5, 6–8).
Triacsin Exposes Fluorescent TG Loss in NLSD and Lipid-
loaded Control Cells—Because the triacsin C might alter TG
hydrolysis by a mechanism unrelated to the ability of the drug
to inhibit acyl-CoA synthetase, we tested the metabolism of TG
synthesized from the fluorescent precursor, C6-NBD-PA. When
incubated with cultured cells, C6-NBD-PA is cleaved to C6-
NBD-diacylglycerol, which enters the cells and is metabolized
to C6-NBD-labeled glycerolipids (19). When a fluorescent glyc-
erolipid is hydrolyzed, the released C6-NBD is not reincorpo-
rated into glycerolipid (19). After a 24-h incubation in medium
with 1.0 mM oleate, NLSD cells and oleate-loaded control cells
incorporated similar amounts of the fluorescent label into TG
and PC (Fig. 2). During a 48-h chase, both cell lines lost the
fluorescent labels rapidly. PC was undetectable after 24 h, and
the rate of decrease from TG was equally rapid in both cell
lines, further supporting the conclusion that the NLSD cells
are not deficient in their ability to hydrolyze TG.
Triacsin Alters the Turnover of [14C]Oleate-labeled Glycero-
lipids—Both cell lines initially incorporated similar amounts of
[14C]oleate into phospholipid. During the chase, however, the
phospholipid fraction in control cells increased 66% (Fig. 1A),
whereas no change was observed in phospholipid labeling in
NLSD cells (Fig. 1B). The addition of triacsin C did not alter
the incorporation or metabolism of total [14C]oleate-labeled
phospholipids, but in NLSD cells, the acyl-CoA synthetase
inhibitor caused the amount of labeled phospholipid to de-
crease 40% during the first 48 h. These results suggest that the
control cells are less dependent on reacylation to maintain label
in phospholipid.
In order to determine which phospholipid species were al-
tered during the chase, phospholipids were separated by TLC
and quantified. 73% of the label was incorporated into PC (Fig.
3). At 48 h in the absence of triacsin, each phospholipid species
in control cells increased 1.4- (PC), 2- (PI-PS), 3- (PE), or
5.7-fold (sphingomyelin), whereas in NLSD cells, labeling of
these phospholipids either decreased (PC and PI-PS) or in-
creased minimally (PE and sphingomyelin) (Fig. 3). In contrast,
when triacsin was present for 48 h, control cells showed a 20%
increase in [14C]oleate incorporation into PC at 48 h, but NLSD
cells showed a 20% decrease (Fig. 3A). Increased label in PC
could result if triacsin increased the amount of cellular fatty
FIG. 1. Turnover of [14C]oleate-labeled glycerolipids in NLSD
cells and in oleate-loaded control cells. Confluent monolayers of
normal human fibroblasts were incubated with [14C]oleate plus 1.0 mM
sodium oleate in 1% BSA, 10% FBS, E-MEM at 37 °C for 24 h. NLSD
fibroblasts were treated similarly except that only 100 mM sodium oleate
was used. After labeling, the medium was removed, and the cultures
were washed three times with 0.1% BSA in PBS warmed at 37 °C. Both
groups of cells were then chased in 10% FBS, E-MEM, 0.1% BSA in the
presence or the absence of triacsin C for 24–96 h. Lipids were extracted
and analyzed as described under “Experimental Procedures.” The pan-
els show the turnover of [14C]oleate from control cell TG and phospho-
lipid (A) and NLSD TG and phospholipid (B). The data points represent
the means 6 S.D. of triplicate samples. Most of the error bars are
hidden by the symbols.
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acid or diacylglycerol, thereby activating CTP:phosphocholine
cytidylyltransferase (20). Differences in the activity of diacyl-
glycerol cholinephosphotransferase were not observed in the
two cell lines. Activities in control cells and NLSD cells were
0.314 and 0.306 nmol/min/mg protein, respectively (averages of
two independent preparations that each varied by less than
10%). During the same chase period, triacsin C caused the
amount of label in PE and sphingomyelin to decrease approx-
imately 40% in both control and NLSD cells at 48 h but had no
effect on the amount of oleic acid incorporated into PI-PS.
The increased labeling of PC and the lack of change in
labeled PI-PS in both the presence and the absence of triacsin
C suggests that normally PC and PI-PS acquire new acyl-
chains both through reacylation and through transfer of la-
beled acyl-groups that remain esterified to a glycerol backbone,
either as a mono- or diacylglycerol. In control cells, triacsin
actually increased incorporation of [14C]oleate into PC during
the chase period, suggesting that the transferred oleate was
still attached to a glycerol backbone. For PE, however, hydro-
lyzed fatty acid must be a major component of the chase label-
ing because this was blocked 40% during the first 48 h of the
chase. Triacsin C also appeared to block the acyl-group addi-
tion to sphingosine to form ceramide, the precursor of sphingo-
myelin (Fig. 3D). In NLSD cells, on the other hand, little
increase in any phospholipid was observed, and in the presence
of triacsin C, labeling decreased greatly in every phospholipid
except PI-PS. These data suggest that in NLSD cells, even in
the absence of triacsin C, neither a fatty acid nor a mono- or
diacylglycerol derived from labeled TG is available for phos-
pholipid synthesis or remodeling.
Triacsin Inhibits de Novo Glycerolipid Synthesis but Not
Reacylation—In order to determine the effect of triacsin C on
glycerolipid synthesis, normal and NLSD cells were incubated
with the acyl-CoA inhibitor plus radiolabeled glycerolipid pre-
cursors. The inhibitor blocked the synthesis of phospholipid
and TG from [3H]glycerol 80 and 99%, respectively, in control
and NLSD fibroblasts (Fig. 4A), indicating that acylation of
glycerol-3-phosphate, lysophosphatidic acid, and DAG were se-
verely impaired. Incorporation of [14C]oleate into TG was
blocked 95%, consistent with impaired acylation in the de novo
pathway. On the other hand, the incorporation of [14C]oleate
into phospholipid in the presence of triacsin remained un-
changed (Fig. 4B), suggesting that the ability of the cells to
reacylate lysophospholipids remained intact. Thus, triacsin C
has differential effects on TG synthesis, de novo phospholipid
synthesis, and reacylation of lysophospholipids. These data
also suggest either that transfer of labeled fatty acid from TG
to phospholipid either does not require activation to an acyl-
CoA or that individual acyl-CoA synthetases exist that differ in
both their sensitivity to triacsin C and in their production of
acyl-CoAs that are present in separate, non-mixing pools that
vary in their metabolic fates. Compartmentalization of acyl-
CoA synthetases and their differential inactivation by triacsin
has been described in yeast (21, 22).
NLSD Cells May Contain Separate Functional Diacylglycerol
Pools for TG and Phospholipid Synthesis—In order to deter-
mine whether TG hydrolysis and fatty acid reutilization allows
the glycerol backbone of TG to be used for phospholipid syn-
thesis, we labeled cells for 19 h with [3H]glycerol (2 mM). We
added 0.1 mM sodium oleate to promote moderate TG synthesis
(1). This was followed by a chase in the presence or the absence
of triacsin C. Control cells incorporated more label into phos-
pholipid than TG; the reverse was true for NLSD cells (Fig. 5).
The 3H label most certainly remains as glycerol because the
80% block in phospholipid synthesis and 100% block in TG
synthesis (Fig. 4A) precludes significant conversion of [3H]glyc-
erol to fatty acid. During the chase in the absence of triacsin,
control cells lost 82% of their labeled TG by 24 h, whereas
NLSD cells lost little [3H]glycerol-labeled TG even after 96 h.
FIG. 3. Turnover of [14C]-labeled phospholipids in NLSD cells
and in oleate-loaded control fibroblasts. Control and NLSD cells
were treated as described in the legend to Fig. 1, and phospholipids
were separated and analyzed as described under “Experimental Proce-
dures.” The panels show the metabolism of [14C]oleate-labeled control
and NLSD PC (A), PE (B), PI-PS (C), and sphingomyelin (D). The data
points represent the means 6 S.D. of triplicate samples. Most of the
error bars are hidden by the symbols.
FIG. 2. Metabolism of C6-NBD-labeled glycerolipids in NLSD
cells and in oleate-loaded control fibroblasts. After incubating
control cells with 1.0 mM sodium oleate for 24 h to increase cellular TG
content, both NLSD and control cells were incubated for 24 h with 5 mM
C6-NBD-PA and 1.0 mM sodium oleate. Cells were washed, and fresh
medium was added. At various intervals, lipids were extracted and
chromatographed as described under “Experimental Procedures.” Flu-
orescent TG spots are deformed by the TG mass present. No DAG was
present (data not shown).
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As demonstrated earlier, this difference is due to dilution of the
[3H]TG into a large unlabeled pool in the NLSD cells. All the
[3H]glycerol label lost from cellular lipids was recovered as free
glycerol in the medium (data not shown). The rate of loss of
[3H]glycerol from phospholipid was similar in both cell lines.
The glycerol uptake studies (Fig. 4), strongly suggest that the
defect in NLSD cells lies in impaired phospholipid synthesis
from a TG-derived mono- or diacylglycerol precursor.
When triacsin C was present to block re-esterification, 30%
of the labeled TG in NLSD cells was lost. The increase in
phospholipid label observed in the presence of triacsin C in
control cells (Fig. 5A) suggests that some MAG or DAG that
would have normally been used for TG resynthesis by the
controls was diverted to phospholipid synthesis. Lack of a sim-
ilar increase in phospholipid labeling in the NLSD cells (Fig.
5B) suggests that the cells cannot use released MAG or DAG
for phospholipid synthesis even though reuse of DAG for TG
synthesis has been blocked.
Analysis of the [3H]glycerol-labeled phospholipids from this
experiment identified the movement of a DAG or MAG precur-
sor more specifically (Fig. 6). Phosphatidylcholine was the ma-
jor labeled phospholipid in both cell lines. When triacsin C was
absent, 55 and 65% of the labeled phosphatidylcholine was lost
from control and NLSD cells, respectively, by 48 h. Triacsin C
prevented much of this loss from control cells during the first
48 h but had little effect on the loss from NLSD cells, suggest-
ing that DAG resulting from TG hydrolysis might be used for
PC biosynthesis in control cells but not by NLSD cells. Surpris-
ingly, PE, which is believed to be synthesized from the same
pool of DAG in the endoplasmic reticulum as PC, showed a
completely different pattern of labeling. In both cell lines about
33% of the [3H]glycerol label was lost from PE during the chase.
FIG. 6. Turnover of [3H]glycerol-labeled phospholipids in con-
trol and NLSD fibroblasts. Control and NLSD cells were treated as
described in the legend to Fig. 5, and phospholipids were separated and
analyzed as described under “Experimental Procedures.” The data
points represent the means 6 S.D. of triplicate samples. Most of the
error bars are hidden by the symbols.
FIG. 4. Triacsin C effect on the uptake and incorporation of
[3H]glycerol and [14C]oleate. Nearly confluent normal and NLSD
fibroblasts were incubated with 5 mM triacsin C plus 0.1 mM sodium
oleate and either 4 mCi of [3H]glycerol/dish (A) or 0.25 mCi of [14C]oleate
(B) for 24 h before lipids were extracted and analyzed as described
under “Experimental Procedures.” Each bar shows the mean 6 S.D. for
three dishes. Each study was performed twice with virtually identical
results.
FIG. 5. Turnover of [3H]glycerol-labeled lipids in control and
NLSD fibroblasts. Nearly confluent control (A) and NLSD (B) cells
were cultured in E-MEM, 10% FBS. Both cell lines were pulsed with
[3H]glycerol (4 mCi/dish) in the presence of 0.1 mM oleate and 1% BSA.
After 19 h, the cells were washed and unlabeled E-MEM, 10% FBS plus
0.1% BSA was added with or without 5 mM triacsin C. At the indicated
times, medium was removed, and cell lipids were extracted and ana-
lyzed as described under “Experimental Procedures.” The data points
represent means 6 S.D. of quadruplicate samples for time 0 and trip-
licate samples for the remaining time points. The error bars are hidden
by the symbols.
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Further, PI-PS labeling changed very little whether or not
triacsin C was present. These differences imply the existence of
different functional precursor pools for each of the phospholipid
species. Others have inferred compartmentalization of several
phospholipid pathways because of differences in both [32P]/[3H]
labeling ratios (23) and channeling of PC metabolites (24).
In order to determine whether oleate-loaded cells would be-
have differently in their metabolism of 3H-labeled glycerolip-
ids, control cells were incubated with 1.0 mM sodium oleate for
24 h, and then both control and NLSD cells were labeled with
[3H]glycerol and 0.1 mM oleate. Both cell lines primarily incor-
porated [3H]glycerol into TG (.78% of total glycerolipid) (Fig.
7). In contrast to the loss of 82% of labeled TG in 24 h from
control cells that had not been oleate-loaded (Fig. 5A), oleate-
loaded control cells lost only 52% of the initial dpm. (Fig. 7A).
Even when triacsin C was present, very little increased loss
was seen. With the NLSD cells, however, no label was lost from
TG unless triacsin was present to block released fatty acid
reacylation of a (presumably) partially hydrolyzed [3H]glycerol
backbone. In the oleate-loaded control cells with triacsin C
present during the chase period, [3H]glycerol label increased in
phospholipid, again suggesting that diacyl[3H]glycerol or
monoacyl[3H]glycerol was being used as a precursor for phos-
pholipid biosynthesis. No such triacsin-induced increase was
observed in the NLSD cells.
When the phospholipids were analyzed, (Fig. 8) the rate of
[3H]glycerol label lost from each phospholipid species in both
cell lines was similar to each other and to the rates of loss from
control cells that had not been oleate-loaded (see Fig. 6). Tri-
acsin C, however, had different effects in the lipid-loaded cells.
It did not block loss of labeled glycerol from PC, suggesting that
the [3H]glycerol was now diluted into a large unlabeled pool of
TG that becomes a precursor for PC synthesis. Additionally,
the slight protection against loss from PI-PS was similar in
both cell lines and in the non-oleate-loaded cells (Fig. 6C). The
labeling pattern was markedly different, however, in PE where
triacsin C prevented the loss of label only in the control cell line
(Compare Figs. 6B and 8B). This experiment suggests that in
oleate-loaded control cells, some of the DAG released from TG
forms a pool from which PE, but not PC, can be synthesized.3 In
the NLSD cells, which always contain a large amount of TG,
3 Because diacylglycerol cholinephosphotransferase activity readily
uses sn-1,2-dioleoylglycerol (17), it is less likely that the inability to use
released DAG for PC synthesis could result from the overwhelming
presence of the sn-1,2-dioleoylglycerol species.
FIG. 7. Turnover of [3H]glycerol-labeled glycerolipids in NLSD
cells and in oleate-loaded control cells. Confluent monolayers of
normal human fibroblasts were incubated with 1.0 mM sodium oleate
for 24 h. Then, these oleate-loaded control cells and NLSD cells were
incubated with [3H]glycerol plus 0.1 mM sodium oleate in 1% BSA, 10%
FBS, E-MEM at 37 °C for 24 h. NLSD fibroblasts were treated similarly
except that only 0.1 mM sodium oleate was used. After labeling, the
medium was removed, and the cells were washed three times. Both
groups of cells were then chased in 10% FBS, E-MEM, 0.1% BSA in the
presence or the absence of triacsin C for 24–96 h. Lipids were extracted
and analyzed as described under “Experimental Procedures.” The data
points represent the means 6 S.D. of triplicate samples. Most of the
error bars are hidden by the symbols.
FIG. 8. Turnover of [3H]glycerol-labeled phospholipids in
NLSD cells and in oleate-loaded control cells. Control and NLSD
cells were treated as described in the legend to Fig. 7, and phospholipids
were separated and analyzed as described under “Experimental Proce-
dures.” The data points represent the means of triplicate samples. Some
of the error bars are hidden by the symbols.
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the phospholipid species showed identical changes in both ex-
periments (compare Figs. 5 and 6 with Figs. 7 and 8) and
appear unable to use this putative DAG pool.
DISCUSSION
NLSD is an autosomal recessive disease characterized by the
accumulation of TG in non-membrane bounded cytosolic drop-
lets in a variety of cell types. Vacuolated neutrophils are pres-
ent in all reported patients, but the presence of ichthyosis, fatty
liver, myopathy, cardiomyopathy, mental retardation, neuro-
sensory hearing loss, and cataracts is variable. The TG content
of control human skin fibroblasts is normally extremely low;
nearly confluent control fibroblasts contained only 0.06% as
much TG as NLSD cells. Others have reported that NLSD
fibroblasts contain 20-fold more TG than in control cells and
that even when lipid is removed from culture medium, NLSD
cells do not substantially decrease their TG content (5, 7).
Because cellular TG content is high and TG turnover is se-
verely impaired, it was hypothesized that NLSD is caused by a
deficiency of a cytosolic lipase that is unable to function
appropriately, either because it is mislocalized or because an
essential activator or colipase is missing (11, 12). Our studies
now clearly show that lipase activity in NLSD cells functions
normally and that the defect instead lies in phospholipid syn-
thesis from a TG-derived diacylglycerol or monoacylglycerol
intermediate.
These studies also strongly suggest that de novo and recy-
cling pools of diacylglycerol may not mix, that cellular acyl-CoA
synthetases differ in their sensitivity to triacsin inhibition, and
that acyl-CoAs may be channeled within separate metabolic
pathways.
In order to increase cell TG content, we supplemented nor-
mal human fibroblasts with 1.0 mM sodium oleate. Cultured
cells incubated with a large amount of fatty acid increase the
synthesis and storage of TG proportional to the amount of
offered fatty acid, whereas net incorporation into phospholipids
and neutral lipids other than TG does not change (1). The
resulting 15-fold increase in TG in oleate-loaded control cells
made them similar to NLSD cells in both TG content and
histological appearance. When oleate-loaded control cells were
put into fresh medium to mobilize the lipid pool, TG decreased
at a rate of approximately 0.5 mg/mg of DNA/day. Because the
TG content in normal human fibroblasts was 0.9 mg/mg of DNA
(Table I), the entire TG storage pool would turn over in less
than 48 h, consistent with previous studies showing rapid
depletion of radiolabeled TG from control fibroblasts (5, 7, 10).
Because the acyl-CoA synthetase inhibitor triacsin C pre-
vents hydrolyzed fatty acids from being activated for re-ester-
ification, the drug can expose the true amount of TG hydrolysis
that occurs in human fibroblasts. When control and NLSD
fibroblasts were treated with triacsin C, both lost the same
absolute mass of TG and hydrolyzed their intracellular TG at
similar rates. Similarly, in cells labeled with [14C]oleate or
[3H]glycerol and chased in the presence of triacsin C, the loss of
label from TG was similar in NLSD cells and in oleate-loaded
control cells. Taken as a whole, these studies show that al-
though NLSD cells contain a TG lipase activity that functions
normally, lipase function is masked because TG is rapidly
resynthesized. This resynthesis appears to occur because of a
block in TG recycling to phospholipid. If fibroblasts and other
non-adipose cells mobilize TG primarily in order to channel a
mono- or diacylglycerol intermediate into phospholipid, the
difference between the rate of TG loss from control and NLSD
cells may approximate the normal turnover of TG to form
phospholipid.
The function of stored TG within cells other than adipocytes
has not been established. Although several studies have indi-
cated that mono- or diacylglycerol derivatives of TG are used
for phospholipid synthesis, how this might occur is unclear.
The terminal steps in the synthesis of both TG and the phos-
pholipids have all been localized to the endoplasmic reticulum;
thus, unless such activities have an additional location associ-
ated with the lipid droplet itself, a mechanism would be re-
quired to transport mono- or diacylglycerol intermediates to
the endoplasmic reticulum. If monoacylglycerols were the ma-
jor intermediates used for phospholipid synthesis, once at the
endoplasmic reticulum, they would require phosphorylation to
form lysophosphatidic acid and esterification to form phospha-
tidic acid (25) (Fig. 9). Phosphatidic acid is the precursor both
for CDP-DAG and the anionic phospholipids PI and PG and for
DAG and its phospholipid products, PC, PE, and PS. If diacyl-
glycerols were the major intermediates transported from the
lipid droplet to the endoplasmic reticulum, PC and PE could be
synthesized directly, or the DAG could be phosphorylated by
diacylglycerol kinase to form phosphatidic acid. In either case,
one might expect concordance of PC and PE synthesis. Lack of
concordance in our studies suggests that the synthesis of PC
and PE from DAG is regulated independently.
We detected major differences in phospholipid synthesis be-
tween control and NLSD fibroblasts. Although the total
amount of [14C]oleate initially incorporated into phospholipid
was similar in control and NLSD cells (Fig. 2), during the
chase, radiolabel increased as much as 5-fold in phospholipid
species in the control cells, whereas there was no change in the
NLSD cells. This progressive increase in labeled phospholipids
during the chase period suggests that acyl groups are actively
recycled from TG to phospholipid. Cook and Spence (1) suggest
that intact DAG produced from TAG forms the backbone for
new phospholipid molecules. Triacsin C seems to decrease this
turnover in PE and sphingomyelin, perhaps by inhibiting acyl-
CoA formation specific for remodeling these phospholipids. To
explain the increase in labeled acyl-groups transferred to PC
when triacsin C is present, one must assume that either acy-
lated DAG is transferred from TG to PC by condensation of the
TG-derived diacylglycerol with CDP-choline (26) or that triac-
sin’s block in fatty acid activation is incomplete and that vir-
tually all of the acyl-CoA synthesized is used to selectively
reacylate lysoPC but not lysoPE. Because triacsin C blocks
incorporation of [3H]glycerol into phospholipid (Fig. 4), selec-
tive regulation seems unlikely, and de novo synthesis of DAG
also seems to be ruled out. Instead, these results suggest that
DAG released from stored TG can be used to form PC and
PI-PS, but that PE and sphingomyelin depend more on the
FIG. 9. Synthesis of glycerolipids via de novo and recycling
pathways. TG, triacylglycerol; DAG, diacylglycerol; MAG, monoacyl-
glycerol; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphati-
dylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine.
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reutilization of released acyl groups. Partial hydrolysis of TG
would produce DAG and fatty acids, both activators of CTP:
phosphocholine cytidylyltransferase, the rate-limiting step in
CDP-choline synthesis.
Although the uptake and incorporation of labeled glycerol is
insignificant in neuroblastoma cells (1) and in Swiss 3T3 cells
(25), in the presence of 0.1 mM oleate, fibroblasts were able to
take up glycerol and incorporate enough of it into phospholipid
and neutral lipid for the study of the metabolism of the labeled
products. Normal and NLSD cells incorporated virtually iden-
tical amounts of [3H]glycerol into total glycerolipid. However,
the loss of labeled PC was rapid compared with that of the
other phospholipids, suggesting a more rapid turnover of the
glycerol backbone of PC. In contrast to the changes observed in
incorporation of labeled oleate into phospholipid, the rate of
glycerol loss was similar in control and NLSD cells.
NLSD cells did not modify the pattern of phospholipid acy-
lation during a 4-day chase (PC decreased slightly during the
chase period, Fig. 2), and triacsin C treatment decreased not
only radiolabeled PE and sphingomyelin but also PC. These
observations suggest that in NLSD cells, the acylated glycerol
backbone of TG cannot be incorporated into phospholipid but is
instead normally reacylated and converted back into TG. In
addition, no accumulation of radiolabeled DAG and/or free
fatty acids is observed in NLSD cells (8, 11). If the cytosolic TG
lipase functions normally and its fatty acid, MAG, and DAG
products cannot be metabolized into phospholipid, phospho-
lipid in NLSD cells must originate primarily via de novo syn-
thesis. When Williams et al. (8) pulsed NLSD fibroblasts with
[14C]oleic acid, oleate was rapidly incorporated into PE and PC,
suggesting that the cellular DAG pool destined for phospho-
lipid synthesis might be extremely small in NLSD cells. The
small DAG pool could be caused by failure to release DAG from
a TG storage pool.
What might be the source of the NLSD clinical phenotype?
The total amount of phospholipids and the distribution of in-
dividual phospholipid species in NLSD cells from one family
was similar to that of control fibroblasts (5). In 24-h labeling
experiments using [14C]octanoic acid or [3H]oleic acid, no dif-
ferences were observed in NLSD or control fibroblasts in the
percentages of label incorporated into the total phospholipid
fraction or into PC, PE, and sphingomyelin (12). If no differ-
ences in the relative amounts of phospholipid species exist in
NLSD cells, there might be abnormalities in the fatty acid
composition of phospholipids that are precursors of lipid second
messengers. Although the fatty acid composition of total lipid
in NLSD fibroblasts was identical to that of control fibroblasts,
individual phospholipid species were not analyzed (5). Further,
fatty acid composition may well be similar in cells grown for
many generations under identical culture conditions. The phe-
notypic abnormalities of ichthyosis, fatty liver, myopathy, and
mental retardation in NLSD make it clear, however, that the
recycling pathway may be critical for the normal function of
skin, liver, muscle, and the central nervous system.
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